JPS59144792A - 3-(beta-chloroethylureide)propyl triethoxy silane - Google Patents

3-(beta-chloroethylureide)propyl triethoxy silane

Info

Publication number
JPS59144792A
JPS59144792A JP272784A JP272784A JPS59144792A JP S59144792 A JPS59144792 A JP S59144792A JP 272784 A JP272784 A JP 272784A JP 272784 A JP272784 A JP 272784A JP S59144792 A JPS59144792 A JP S59144792A
Authority
JP
Japan
Prior art keywords
beta
chloroethylureido
chloroethylureide
triethoxy silane
propyl triethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP272784A
Other languages
Japanese (ja)
Other versions
JPS6245235B2 (en
Inventor
Shozo Kato
加藤 祥三
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokuyama Corp
Original Assignee
Tokuyama Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokuyama Corp filed Critical Tokuyama Corp
Priority to JP272784A priority Critical patent/JPS59144792A/en
Publication of JPS59144792A publication Critical patent/JPS59144792A/en
Publication of JPS6245235B2 publication Critical patent/JPS6245235B2/ja
Granted legal-status Critical Current

Links

Abstract

NEW MATERIAL:3-(beta-Chloroethylureido)propyltriethoxysilane. USE:A starting material for producing polysilsesquioxane, a carcinostatic agent. PREPARATION:The reaction between 3-aminopropyltriethoxysilane and beta-chlroethyl isocyanate gives the objective compound.

Description

【発明の詳細な説明】 本発明は新規な化合物である、5−(β−クロロエチル
ウレイド)プロピルトリエトキシシランを提供するもの
である。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides a novel compound, 5-(β-chloroethylureido)propyltriethoxysilane.

本発明者は各種ポリシルセスキオキサンを合成し、それ
らの生理活性につき種々研究を行なって来た。その結果
、新規な化合物である、3−(β−クロロエチルウレイ
ド)プロピルトリエトキシシラン及びこれから誘導され
る新規なポリシルセスキオキサンを合成し、該ポリシル
セスキオキサンが優れた生理活性、殊に制癌活性を有す
ることを確認し、本発明を完成するに至った。
The present inventor has synthesized various polysilsesquioxanes and conducted various studies on their physiological activities. As a result, a new compound, 3-(β-chloroethylureido)propyltriethoxysilane, and a new polysilsesquioxane derived from it were synthesized, and the polysilsesquioxane has excellent biological activity, In particular, it was confirmed that it has anticancer activity, and the present invention was completed.

本発明の3−(β−クロロエチルウレイド)プロピルト
リエトキシシランは 1 (01130H20)3SiOH2cH3c’a2NH
ONEca20H2cz、  (1)の式で示される新
規な化合物である。その製造方法は特に限定されず、例
えば、3−アミノプロピルトリエトキシシランとβ−ク
ロロエチルイソシアネートとを反応させる方法、3−イ
ソシアナートプロピルトリエトキシシランとβ−クロロ
エチルアミンとを反応させる方法環が挙げられる。一般
に、これらの反応は、無水条件下においては室温におい
ても定量的に進行する。
The 3-(β-chloroethylureido)propyltriethoxysilane of the present invention is 1 (01130H20)3SiOH2cH3c'a2NH
ONEca20H2cz is a novel compound represented by the formula (1). The manufacturing method is not particularly limited, and for example, a method of reacting 3-aminopropyltriethoxysilane and β-chloroethyl isocyanate, a method of reacting 3-isocyanatopropyltriethoxysilane and β-chloroethylamine, etc. Can be mentioned. Generally, these reactions proceed quantitatively under anhydrous conditions even at room temperature.

(1)式で示される3−(β−クロロエチルウレイド)
プロピルトリエトキシシランは低融点の白色結晶状固体
であり、次ぎの(イ)〜(ハ)のような手段でその構造
を確認することができる。
3-(β-chloroethylureido) represented by formula (1)
Propyltriethoxysilane is a white crystalline solid with a low melting point, and its structure can be confirmed by the following methods (a) to (c).

(イ) 赤外吸収スペクトルを測定することにより、3
400 in−’ に強い吸収を示すことがらNH基の
存在、1705fi−1に強い特性吸収を示すことから
ウレイドカルボニル基の存在を知重f%を求め、さらに
認知された各元素の重i%の和を100から減じること
により、酸素元素の重i:チを算出することが出来、従
って該生成物の組成式を決定することができる。
(b) By measuring the infrared absorption spectrum, 3
The presence of NH group, which shows strong absorption at 400 in-', and the presence of ureido carbonyl group, which shows strong characteristic absorption at 1705 fi-1, was determined by the known weight f%, and then the weight i% of each recognized element. By subtracting the sum from 100, the weight of the oxygen element i:h can be calculated, and the compositional formula of the product can therefore be determined.

(ハ) 13C−核磁気共鳴スペクトルを測定すること
によって該化合物中の炭素原子の個数、炭素鎖の配列様
式、炭素原子の結合様式を知ることが出来る。すなわち
、測定したスペクトルには化学シフト値(δ、ppm 
) 19.7.59.7、?、6.22.4.52.1
(重複)、4368の合計6種のピークを示し、その化
学シフトの値および強度から後述する実施例に示した如
く、3個のエチル基、珪素原子に直結した1個の炭素原
子、NH基に隣接した2個の炭素原子、塩素原子に直結
した1個の炭素原子およびaiiz基に挟まれた1個の
炭素原子の存在を確蛯することが出来る。
(c) By measuring the 13C-nuclear magnetic resonance spectrum, the number of carbon atoms in the compound, the arrangement of carbon chains, and the bonding mode of carbon atoms can be determined. That is, the measured spectrum has a chemical shift value (δ, ppm
) 19.7.59.7,? , 6.22.4.52.1
(overlapping), 4368, and the chemical shift values and intensities indicate that three ethyl groups, one carbon atom directly bonded to a silicon atom, and an NH group, as shown in the examples below. The presence of two carbon atoms adjacent to , one carbon atom directly connected to the chlorine atom, and one carbon atom sandwiched between the aiiz groups can be confirmed.

本発明の6−(β−クロロエチルウレイド)フロビルト
リエトキシシランは加水分解することによって容易に一
般式、 で示されるクロロエチルウレイドプロビルボリシルセス
キオキサンとすることが出来る。上記ポリシルセスキオ
キサンは公知のポリシルセスキオキサンに比べて著しく
生理活性にすぐれていて、特に制癌活性にすぐれた効果
を発揮するすぐれた化合物である。従って本発明で提供
する化合物は上記ポリシルセスキオキサンの原料として
極めて有用なものである。
By hydrolyzing the 6-(β-chloroethylureido)furobyltriethoxysilane of the present invention, it can be easily converted into chloroethylureidoprobilbolysilsesquioxane represented by the general formula: The above-mentioned polysilsesquioxane has significantly superior physiological activity compared to known polysilsesquioxanes, and is an excellent compound that exhibits particularly excellent anticancer activity. Therefore, the compound provided by the present invention is extremely useful as a raw material for the above-mentioned polysilsesquioxane.

以下本発明を更に明確に説明するため実施例及び参考例
を示すが本発明はこれらの実施例に限定されるものでは
ない。
EXAMPLES Below, Examples and Reference Examples will be shown to explain the present invention more clearly, but the present invention is not limited to these Examples.

実施例1 5−(β−クロロエチルウレイド)フロビルトリエトキ
シシランの製法。
Example 1 Method for producing 5-(β-chloroethylureido)furobyltriethoxysilane.

蒸留精製した3−アミノプロピルトリエトキシシラン(
21,00g、、95 mmols )の無水へキザ/
溶液(4omりにβ−クロロエチルイソシアネート(1
1,00g、、 104 mmole )を磁気攪拌下
に滴下すると、穏やかに発熱しながら反応が開始した。
Distilled purified 3-aminopropyltriethoxysilane (
21,00g, 95 mmols) of anhydrous hekiza/
solution (β-chloroethyl isocyanate (1
When 1,00 g, 104 mmole) was added dropwise under magnetic stirring, the reaction started with mild heat generation.

滴下終了後反応液を湯浴上で一時間加熱した。低沸点物
を蒸留によって除去した後、残渣を油浴上(約100℃
)で真空乾燥すると無色粘稠物が得られ、放置すると白
色結晶(28,70g、)となった。その赤外吸収スペ
クトルを測定したところ、3400σ−1にNHに基づ
く吸収および1705α−1にウレイドカルボニルに基
づく強い吸収を示した。その元素分析値はH8,10チ
、041.71チ、c+t11.89チであっ【、O,
、H!7N2040zSi (326,91)の組成式
に対する計算値であるH8.33%、C44,09チ、
H8,57%、O/=10.85チによく−5= 一致した。さらにI3□−核磁気共鳴スペクトルの解析
結果(J、ppm:テトラメチルシラン基準)は次の通
りであった。
After the dropwise addition was completed, the reaction solution was heated on a hot water bath for one hour. After removing low boilers by distillation, the residue was heated on an oil bath (approximately 100°C
) to obtain a colorless viscous substance, which became white crystals (28.70 g) upon standing. When its infrared absorption spectrum was measured, it showed an absorption based on NH at 3400σ-1 and a strong absorption based on ureido carbonyl at 1705α-1. Its elemental analysis values were H8.10chi, 041.71chi, c+t11.89chi [, O,
,H! Calculated values for the composition formula of 7N2040zSi (326,91) H8.33%, C44,09chi,
H8, 57%, O/=10.85, in good agreement with -5=. Further, the analysis results of I3□-nuclear magnetic resonance spectrum (J, ppm: tetramethylsilane standard) were as follows.

1 上記の結果より、単離生成物が3−(β−クロロエチル
ウレイド)プロピルトリエトキシシランであることが明
らかとなった。収率は用いた3−アミノプロピルトリエ
トキシシランに対し92.5 % (88mmole 
)であった。
1 From the above results, it became clear that the isolated product was 3-(β-chloroethylureido)propyltriethoxysilane. The yield was 92.5% (88 mmole) based on the 3-aminopropyltriethoxysilane used.
)Met.

参考例; 実施例1で得た3−(β−クロロエチルウレイド)プロ
ピルトリエトキシシラン(53,0OL)に水(701
F7)を加え、二夜攪拌した後、低沸点物を蒸留によっ
て除き、残渣を油浴上(約70℃)で−日間真空乾燥す
ることにより白色固体(s7.63g、)を得た。この
固体につい 6− て赤外吸収スペクトルを測定したところ、33[I Q
 crn−’ にNHに基づく吸収および17051m
−’にウレイドカルボニルに基づく強い吸収を示した。
Reference example: Water (701
After stirring for two nights, low-boiling substances were removed by distillation, and the residue was vacuum-dried on an oil bath (approximately 70°C) for -1 day to obtain a white solid (s7.63 g). When the infrared absorption spectrum of this solid was measured, it was found that 33[IQ
NH-based absorption and 17051m in crn-'
-' showed strong absorption based on ureido carbonyl.

その元素分析値はN5.75チ、050.72チ、N1
2.45%、at15.91チであって、3−(β−ク
ロロエチルウレイド)プロピルポリシルセスキオキサン
の一水和物(06H1jlN20□、5ata1・N2
0)に対する計算値であるH6.04チ、a 30.8
5 q6 N M 11−99%、cJ15.1796
によく一致した。さらに該白色固体を少量の水に溶かし
テトラメチルシラン基準で+”O−核磁気共鳴スペクト
ルを測定した結果は次の通りであった(値はδ、ppm
 ) 。
Its elemental analysis values are N5.75chi, 050.72chi, N1
2.45%, at15.91%, 3-(β-chloroethylureido)propylpolysilsesquioxane monohydrate (06H1jlN20□, 5ata1・N2
H6.04 which is the calculated value for 0), a 30.8
5 q6 N M 11-99%, cJ15.1796
It matched well. Furthermore, the white solid was dissolved in a small amount of water and the +"O- nuclear magnetic resonance spectrum was measured using tetramethylsilane as a standard. The results were as follows (values are δ, ppm
).

1 以上の結果から、得られた白色固体が3−(β−クロロ
エチルウレイド)プロピルポリシルセスキオキサンであ
ることが明らかとなった。収率はほぼ定量的であった。
1 From the above results, it became clear that the obtained white solid was 3-(β-chloroethylureido)propyl polysilsesquioxane. The yield was almost quantitative.

次いで前記得られた3−(β−クロロエチルウレイド)
プロピルポリシルセスキオキサンを界面活性剤ツイーン
80を含む生理食塩水に加えて規定量の試料を含む88
1類の試料溶液(616111i+/KP、199 m
g/Kps  15811g/KP、12 6 冨g 
/Ky  、   1  o   omg /KP 、
    7   q  肩g / リ 、   6 3
Q / KP 、40 mg /す)を作成した。この
試料溶液を用いて体重201前後の0DFI系マウスの
雄36匹および雌8匹の腹腔内に注射投与して20日間
試験を行ない、急性毒性値をリッチフィールドとウィル
コクソンの方法によりTJD50およびTJDIOを求
めたところ、それぞれ112チルウレイド)プロピルポ
リシルセスキオキサンを界面活性剤ツイーン80を含む
生理食塩水に加えて規定量の試料を含む試料溶液を作成
した。該試料溶液を、エールリクヒ癌細胞数5×106
 個を有するスイスマウス(雄)6匹の腹腔内に0.5
mlずつ9日間連続注射投与した。60日間にわたる延
命効果の結果から、平均生存日数(MST)を求め、対
照群(30匹)の平均生存日数と比較することによりT
/。チを算出した。即ち、平均生存日数な験体(T)と
対照体(0)について求め、T10×100帳)で算出
した。その結果を表1に示す。
Then, the obtained 3-(β-chloroethylureido)
Propylpolysilsesquioxane was added to a saline solution containing the surfactant Tween 80 and a specified amount of the sample was added to the sample.
Type 1 sample solution (616111i+/KP, 199 m
g/Kps 15811g/KP, 12 6 Tomi g
/Ky, 1 omg /KP,
7 q shoulder g / li, 6 3
Q/KP, 40 mg/su) was prepared. This sample solution was intraperitoneally injected into 36 male and 8 female 0DFI mice weighing around 201 kg and tested for 20 days. For the determination, a sample solution containing a specified amount of the sample was prepared by adding each 112 thylureido)propyl polysilsesquioxane to a physiological saline solution containing the surfactant Tween 80. The sample solution was divided into 5 x 106 Ehrlich cancer cells.
Intraperitoneally into 6 Swiss mice (male) with 0.5
ml was continuously injected for 9 days. From the results of the survival effect over 60 days, the mean survival days (MST) was calculated and compared with the mean survival days of the control group (30 animals).
/. We calculated Chi. That is, the average survival days were determined for the test subject (T) and the control subject (0), and calculated as T10 x 100 days). The results are shown in Table 1.

以下余白  9− −10−Margin below 9- -10-

Claims (1)

【特許請求の範囲】[Claims] (1)3−(β−クロロエチルウレイド)フロビルトリ
エトキシシラ/
(1) 3-(β-chloroethylureido)furobyltriethoxysila/
JP272784A 1984-01-12 1984-01-12 3-(beta-chloroethylureide)propyl triethoxy silane Granted JPS59144792A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP272784A JPS59144792A (en) 1984-01-12 1984-01-12 3-(beta-chloroethylureide)propyl triethoxy silane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP272784A JPS59144792A (en) 1984-01-12 1984-01-12 3-(beta-chloroethylureide)propyl triethoxy silane

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP18140880A Division JPS57105423A (en) 1980-12-23 1980-12-23 Chloroethylureidopropylpolysilsesquioxane

Publications (2)

Publication Number Publication Date
JPS59144792A true JPS59144792A (en) 1984-08-18
JPS6245235B2 JPS6245235B2 (en) 1987-09-25

Family

ID=11537342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP272784A Granted JPS59144792A (en) 1984-01-12 1984-01-12 3-(beta-chloroethylureide)propyl triethoxy silane

Country Status (1)

Country Link
JP (1) JPS59144792A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2947087A1 (en) * 2014-05-15 2015-11-25 Evonik Degussa GmbH Urea-containing silanes, process for preparation thereof and use thereof
KR20150131985A (en) * 2014-05-15 2015-11-25 에보닉 인두스트리에스 아게 Process for preparing urea-containing mercaptosilanes
JP2015218167A (en) * 2014-05-15 2015-12-07 エボニック インダストリーズ アクチエンゲゼルシャフトEvonik Industries AG Urea-containing silane, manufacturing method therefor and their use
JP2015218171A (en) * 2014-05-15 2015-12-07 エボニック インダストリーズ アクチエンゲゼルシャフトEvonik Industries AG Urea-containing mercaptosilane, manufacturing method therefor and their use

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2947087A1 (en) * 2014-05-15 2015-11-25 Evonik Degussa GmbH Urea-containing silanes, process for preparation thereof and use thereof
KR20150131985A (en) * 2014-05-15 2015-11-25 에보닉 인두스트리에스 아게 Process for preparing urea-containing mercaptosilanes
JP2015218167A (en) * 2014-05-15 2015-12-07 エボニック インダストリーズ アクチエンゲゼルシャフトEvonik Industries AG Urea-containing silane, manufacturing method therefor and their use
JP2015218171A (en) * 2014-05-15 2015-12-07 エボニック インダストリーズ アクチエンゲゼルシャフトEvonik Industries AG Urea-containing mercaptosilane, manufacturing method therefor and their use
JP2015218169A (en) * 2014-05-15 2015-12-07 エボニック インダストリーズ アクチエンゲゼルシャフトEvonik Industries AG Manufacturing method of urea-containing mercaptosilane
US9388201B2 (en) 2014-05-15 2016-07-12 Evonik Degussa Gmbh Urea-containing silanes, process for preparation thereof and use thereof
US9388200B2 (en) 2014-05-15 2016-07-12 Evonik Degussa Gmbh Urea-containing mercaptosilanes, process for preparation thereof and use thereof
CN105884815A (en) * 2014-05-15 2016-08-24 赢创德固赛有限公司 Urea-containing silanes, process for preparation thereof and use thereof
US9440998B2 (en) 2014-05-15 2016-09-13 Evonik Degussa Gmbh Process for preparing urea-containing mercaptosilanes
US9527873B2 (en) 2014-05-15 2016-12-27 Evonik Degussa Gmbh Urea-containing silanes, process for preparation thereof and use thereof

Also Published As

Publication number Publication date
JPS6245235B2 (en) 1987-09-25

Similar Documents

Publication Publication Date Title
Marans et al. Preparation of Organofluorosilanes Using Aqueous Hydrofluoric Acid1
JPS59144792A (en) 3-(beta-chloroethylureide)propyl triethoxy silane
Gillette et al. Reactions of tetramesityldisilene with azides: synthesis of disilaaziridines
JPS5951282A (en) Manufacture of iminopyrolidinyl indole
Blas et al. Synthesis and characterization of titanium (IV) complexes with silylated schiff bases
JPS5821669A (en) Preparation of 2-(1-acylaminoalkyl)-6-methyl-4(3h)- pyrimidinone
JPS59144793A (en) 3-(beta-chloroethylamino)propyltriethoxysilane
Ding et al. An unexpected product isolated during the decomposition of an isomer of Re2Cl2 (μ-dppm) 2 (CO)(CNXyl) 3—synthesis and structural characterization of [Na (dppmO2) 3] Cl· 2H2O· C6H6
LiChen et al. Synthesis and characterization of ferrocenylalkoxygermatranes and crystal structures of FcCH2OGe (OCH2CH2) 3N and FcCH (CH3) OGe (OCH2CH2) 3N1
Godefroi et al. Some Derivatives of 2-Amino-3-bromotetrahydropyran
SU1168562A1 (en) Method of obtaining 4-(9-acridinyl)pyridilmethane
Twamley et al. Unsymmetric dipnictenes-synthesis and characterization of MesP= EC~ 6H~ 3-2, 6-Trip~ 2 (E= As or Sb; Mes= C~ 6H~ 2-2, 4, 6-Me~ 3, Trip= C~ 6H~ 2-2, 4, 6-Pr^ i~ 3)
SU1502569A1 (en) Method of producing 3.6-diformyl-9-methylcarbasole
JPH02290885A (en) Organosilicon compound and its production
JPS63170387A (en) Organosilicon compound, production thereof and antitumor agent containing said compound as active ingredient
JPS637552B2 (en)
JPS59144794A (en) Heterocyclic five-membered phosphorus derivative
JPS58198474A (en) Aminomethylenemalonic ester derivative, its preparation, and fungicide
JPH0341065A (en) Aryloxyalkylisothiourea hydrobromides
JPH0144194B2 (en)
JPS58140080A (en) Preparation of thiocytosine
JPH0240338A (en) Production of 1-halogeno-3,3,3-trifluoroacetone
JPS6377888A (en) Germanium bis-salicylate and production thereof
Power Unsymmetric dipnictenes—synthesis and characterization of MesP [double bond, length half m-dash] EC 6 H 3-2, 6-Trip 2 (E= As or Sb; Mes= C 6 H 2-2, 4, 6-Me 3, Trip= C 6 H 2-2, 4, 6-Pr i 3)
JPS6248681A (en) Production of nitromethylene derivative